Aim Rule 26



Description of the business
Our Business

Names of directors and brief biographical details of each
Board of directors

Description of directors’ responsibilities
The Board is responsible for strategic and major operational issues affecting the Group. It reviews financial performance and regulatory compliance, monitors key performance indicators, and considers any matters of significance to the Group.

Board Committees
Board of directors

Country of incorporation and main country of operation
Accrol Group Holdings plc is incorporated in England (Registration no 09019496), its main country of operation.

Registered office
Delta Building
Roman Road

Most recent annual report
Annual Report 2023

Notice of meeting
Notice of meeting

Articles of Association
Articles of Association

Details of any other exchanges or trading platforms
London Stock Exchange (AIM)

The number of AIM securities in issue (noting any held as treasury shares) and, insofar as the Group is aware, the percentage of AIM securities that is not in public hands together with the identity and percentage holdings of its significant shareholders.
Shareholder and securities information

Details of any restrictions on the transfer of securities

Most recent annual report published pursuant to rule 19 and all half-yearly, quarterly or similar reports published since the last annual report pursuant to rule 18

Notifications made by the Group in the past 12 months
RNS announcements

Latest Admission Document and any Circulars issued in the past 12 months
Company reports presentations and circulars

Corporate Governance Code
The Board has chosen to adopt The Quoted Companies Alliance (QCA) Corporate Governance Code (the Code). The document below sets out how we comply with the Code by reference to each of the ten principles it contains.
Statement regarding QCA Code

Takeover Code
As an AIM traded UK registered company, Accrol Group Holdings plc is subject to the UK City Code on Takeovers and Mergers legislation.

Details of its nominated adviser and other key advisers


Last updated: 14 February 2024